These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
127 related items for PubMed ID: 2179691
21. [What are the indications for proton pump inhibitors? R. Arnold, Marburg, elaborates on the clinical aspects of the controversy regarding lansoprazole. Interview by Gerrit Lichtenberg]. Arnold R. Fortschr Med; 1994 Jan 20; 112(1-2):44-5. PubMed ID: 8144120 [No Abstract] [Full Text] [Related]
22. Criteria for use of omeprazole in adult inpatients and outpatients. Lajoie C. Clin Pharm; 1992 Feb 20; 11(2):177-9. PubMed ID: 1551300 [No Abstract] [Full Text] [Related]
23. The clinical safety of omeprazole. Sölvell L. Scand J Gastroenterol Suppl; 1989 Feb 20; 166():106-10; discussion 111-3. PubMed ID: 2690327 [Abstract] [Full Text] [Related]
24. Treatment of patients with Zollinger-Ellison syndrome. Mignon M, Pospai D, Forestier S, Vatier J, Vallot T. Clin Ther; 1993 Feb 20; 15 Suppl B():22-31. PubMed ID: 8205592 [Abstract] [Full Text] [Related]
29. [Cimetidine; new hope for ulcer patients?]. Festen HP, Lamersen CB, van Tongeren JH. Ned Tijdschr Geneeskd; 1978 Jun 17; 122(24):866-70. PubMed ID: 351434 [No Abstract] [Full Text] [Related]
30. Clinical perspectives of drugs inhibiting acid secretion--H+K+-ATPase inhibitors. Walan A. Scand J Gastroenterol Suppl; 1986 Jun 17; 125():50-4. PubMed ID: 3029857 [Abstract] [Full Text] [Related]
31. Is there a need for strong gastric acid inhibition in clinical practice? Lamers CB. Digestion; 1989 Jun 17; 44 Suppl 1():4-8. PubMed ID: 2691309 [Abstract] [Full Text] [Related]
32. Recent advances in the management of gastric acid hypersecretion in patients with Zollinger-Ellison syndrome. Maton PN, Gardner JD, Jensen RT. Gastroenterol Clin North Am; 1989 Dec 17; 18(4):847-63. PubMed ID: 2575602 [Abstract] [Full Text] [Related]
33. [Losek (omeprazole), a new therapeutic agent in the treatment of peptic ulcer and hyperacidity states]. Bulgakov SA. Klin Med (Mosk); 1995 Dec 17; 73(5):11-6. PubMed ID: 8815266 [No Abstract] [Full Text] [Related]
34. [Risk for developing tumors in therapy with the proton pump inhibitor omeprazole]. Eissele R, Arnold R. Versicherungsmedizin; 1993 Aug 01; 45(4):126-9. PubMed ID: 8379045 [Abstract] [Full Text] [Related]
35. [Omeprazole. An effective antisecretory agent in ulcerative disease and reflux esophagitis]. Lauritsen K, Laursen LS, Madsen JR. Ugeskr Laeger; 1989 Jul 10; 151(28):1831-3. PubMed ID: 2773093 [No Abstract] [Full Text] [Related]
36. [Cimetidine]. Castro Lde P, Salgado JA. AMB Rev Assoc Med Bras; 1981 Oct 10; 27(10):301-4. PubMed ID: 7045988 [No Abstract] [Full Text] [Related]
38. Omeprazole: a new drug for the treatment of acid-peptic diseases. Falk GW. Cleve Clin J Med; 1991 Apr 19; 58(5):418-27. PubMed ID: 1934456 [Abstract] [Full Text] [Related]
39. [Lansoprazole--profile of a new proton pump inhibitor]. Seifert E. Leber Magen Darm; 1994 Mar 19; 24(2):66-8, 71. PubMed ID: 8196467 [Abstract] [Full Text] [Related]